Kimberly-Clark Ballard Trach Care Covered Under New CMS Reimbursement Code
DRAPER, Utah -- Kimberly-Clark Health Care, a market leader in closed suction systems, announced that effective immediately, its BALLARD* TRACH CARE* Closed Tracheal Suction Systems are now covered under CMS code A4605 (formerly A4609 and A4610) and has a set fee schedule of $16.40.
"We applaud the fact that CMS has made a meaningful change in the reimbursement of closed suction catheters," said Tim Dye, general manager, critical care and temperature management, Kimberly-Clark Health Care. "Closed suctioning protects those patients with artificial airways by reducing the risk of infection that might occur from cross-contamination. It is also significantly more comfortable for the patient."
The closed-suction platform is easier to use in home care and long-term care settings and offers:
-- Protection to the caregiver from unnecessary exposure to patients' body fluids
-- Proper adherence to recommended universal precautions
-- Reduction of risk for infection and cross-contamination
"We believe the action taken by CMS is a positive step towards making this valuable therapy available to patients as they transition from acute care into the home care setting," said Dye.
Source: Kimberly-Clark Health Care
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
